AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 126 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $225,086 | -40.4% | 35,280 | +3.7% | 0.00% | -50.0% |
| Q2 2023 | $377,348 | -22.0% | 34,026 | +8.0% | 0.00% | -33.3% |
| Q1 2023 | $483,617 | -13.9% | 31,506 | +24.5% | 0.00% | -25.0% |
| Q4 2022 | $561,629 | +41.5% | 25,310 | +4.1% | 0.00% | +33.3% |
| Q3 2022 | $397,000 | +19.6% | 24,313 | +6.2% | 0.00% | +50.0% |
| Q2 2022 | $332,000 | -3.8% | 22,883 | +22.4% | 0.00% | 0.0% |
| Q1 2022 | $345,000 | -27.5% | 18,697 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $476,000 | -6.3% | 20,013 | -2.9% | 0.00% | -33.3% |
| Q3 2021 | $508,000 | +21.2% | 20,612 | +21.5% | 0.00% | +200.0% |
| Q2 2021 | $419,000 | +8.0% | 16,960 | -4.6% | 0.00% | 0.0% |
| Q1 2021 | $388,000 | +56.5% | 17,769 | +82.8% | 0.00% | 0.0% |
| Q4 2020 | $248,000 | -12.1% | 9,722 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $282,000 | – | 10,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
| COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
| 5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
| RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
| Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
| RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
| Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
| Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
| AtonRa Partners | 18,970 | $121,029 | 0.25% |
| Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |